BioCryst Pharmaceuticals BCRX Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's effective income tax rate reconciliation, state and local income taxes, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's effective income tax rate reconciliation, state and local income taxes, amount?
- BioCryst Pharmaceuticals (BCRX) reported effective income tax rate reconciliation, state and local income taxes, amount of $642.25K in Q4 2025.
- How has BioCryst Pharmaceuticals's effective income tax rate reconciliation, state and local income taxes, amount changed year-over-year?
- BioCryst Pharmaceuticals's effective income tax rate reconciliation, state and local income taxes, amount increased by 169.0% year-over-year, from $238.75K to $642.25K.
- What is the long-term trend for BioCryst Pharmaceuticals's effective income tax rate reconciliation, state and local income taxes, amount?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's effective income tax rate reconciliation, state and local income taxes, amount has grown at a 2.9% compound annual growth rate (CAGR), from -$2.29M to $2.57M.
- What does effective income tax rate reconciliation, state and local income taxes, amount mean?
- The adjustment to the federal statutory tax expense to account for the impact of state and local income taxes. This metric highlights the tax burden or benefit resulting from the company's geographic footprint across various sub-national jurisdictions.